Anti-Mouse CD22 In Vivo Antibody – Ultra Low Endotoxin (Cy34.1)

Anti-Mouse CD22 In Vivo Antibody – Ultra Low Endotoxin (Cy34.1)

Catalog Number:
A001437672ICH
Mfr. No.:
ICH1181UL
Price:
$832
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Purification method: This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
          Isotype Control: Mouse IgG1 Isotype Control for In Vivo - Low Endotoxin [HKSP] (ICH2247)
          Endotoxin: ≤ 0.75 EU/mg as determined by the LAL method
          Aggregation: Aggregation level ≤ 1%

          Please contact us at for specific academic pricing.

      • Properties
        • Host
          mouse
          Isotype
          IgG1
          Reactivity
          mouse
          Clone
          Cy34.1
          Purification
          >98% by SDS-PAGE and HPLC
          Formulation
          This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added.
          Storage
          This antibody is stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at –80°C. Avoid Repeated Freeze Thaw Cycles.
          Molecular Weight
          ≥ 5.0 mg/ml
          Regulatory Status
          The suggested concentration for this CD22 (clone Cy34.1) antibody for staining cells in flow cytometry is ≤ 1.0 μg per 10^6 cells in a volume of 100 μl. Titration of the reagent is recommended for optimal performance for each application.
          Antigen
          (Gene ID:Lyb-8.2)

          * Products are for research use only. Not for use in diagnostic or therapeutic procedures.

      • Applications
        • Application
          Flow Cytometry; Depletion

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.